trial · primary record
JZP3507
Meningioma
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2031-10-16 |
| Primary endpoint | Overall Response Rate (ORR) as Assessed by Response Assessment in Neuro-Oncology (RANO) Criteria and Evaluated by Blinded Independent Central Review (BICR) |
| Registry ID | NCT07533942 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:35.700Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07533942
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.